
|Videos|June 28, 2011
Dr. Kris Discusses Tests Available for Lung Cancer
Author(s)Mark G. Kris, MD, FASCO
Dr. Kris from Memorial Sloan-Kettering Discusses Tests Available for Lung Cancer
Advertisement
Mark G. Kris, MD, the chief of Thoracic Oncology Service at Memorial Sloan-Kettering Cancer Center discusses tests available for lung cancer patients.
FISH is a poor cousin of mutation and that virtually all mutated patients are FISH positive. Tests for mutations are more potent predictors and most trials use them. Some of the tests are done by FISH test. They look for MET amplifications and EML4-ALK as a FISH test.
Dr. Kris says the vast majority of tests are for mutations. He says
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
3
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
4
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
5




































